Avidity Biosciences Stock Net Income
| RNA Stock | USD 72.60 0.05 0.07% |
As of the 23rd of January, Avidity Biosciences shows the Mean Deviation of 1.44, risk adjusted performance of 0.1084, and Coefficient Of Variation of 739.68. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Avidity Biosciences, as well as the relationship between them.
Avidity Biosciences Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 435.7316 | Revenue | Earnings Share (4.19) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -290.1 M | -275.6 M | |
| Net Loss | -156.6 M | -148.8 M | |
| Net Loss | -290.1 M | -275.6 M | |
| Net Loss | (3.32) | (3.49) | |
| Net Income Per E B T | 0.96 | 0.85 |
Avidity | Net Income | Build AI portfolio with Avidity Stock |
Latest Avidity Biosciences' Net Income Growth Pattern
Below is the plot of the Net Income of Avidity Biosciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Avidity Biosciences financial statement analysis. It represents the amount of money remaining after all of Avidity Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Avidity Biosciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avidity Biosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (322.3 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Avidity Net Income Regression Statistics
| Arithmetic Mean | (91,925,354) | |
| Coefficient Of Variation | (125.08) | |
| Mean Deviation | 98,241,987 | |
| Median | (11,934,000) | |
| Standard Deviation | 114,981,388 | |
| Sample Variance | 13220.7T | |
| Range | 310.4M | |
| R-Value | (0.85) | |
| Mean Square Error | 3797.1T | |
| R-Squared | 0.73 | |
| Significance | 0.000012 | |
| Slope | (19,464,344) | |
| Total Sum of Squares | 211531.5T |
Avidity Net Income History
Other Fundumenentals of Avidity Biosciences
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Avidity Biosciences Net Income component correlations
Avidity Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Avidity Biosciences is extremely important. It helps to project a fair market value of Avidity Stock properly, considering its historical fundamentals such as Net Income. Since Avidity Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avidity Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avidity Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. If investors know Avidity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avidity Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.19) | Revenue Per Share | Quarterly Revenue Growth 4.34 | Return On Assets | Return On Equity |
The market value of Avidity Biosciences is measured differently than its book value, which is the value of Avidity that is recorded on the company's balance sheet. Investors also form their own opinion of Avidity Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Avidity Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avidity Biosciences' market value can be influenced by many factors that don't directly affect Avidity Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avidity Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avidity Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avidity Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Avidity Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Avidity Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Avidity Biosciences.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Avidity Biosciences on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Avidity Biosciences or generate 0.0% return on investment in Avidity Biosciences over 90 days. Avidity Biosciences is related to or competes with Jazz Pharmaceuticals, Madrigal Pharmaceuticals, Caris Life, Moderna, Abivax SA, Cytokinetics, and Nuvalent. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies More
Avidity Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Avidity Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Avidity Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.0 | |||
| Information Ratio | 0.1155 | |||
| Maximum Drawdown | 42.94 | |||
| Value At Risk | (0.49) | |||
| Potential Upside | 1.24 |
Avidity Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avidity Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Avidity Biosciences' standard deviation. In reality, there are many statistical measures that can use Avidity Biosciences historical prices to predict the future Avidity Biosciences' volatility.| Risk Adjusted Performance | 0.1084 | |||
| Jensen Alpha | 0.667 | |||
| Total Risk Alpha | 0.0315 | |||
| Sortino Ratio | 0.6075 | |||
| Treynor Ratio | 1.78 |
Avidity Biosciences January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1084 | |||
| Market Risk Adjusted Performance | 1.79 | |||
| Mean Deviation | 1.44 | |||
| Downside Deviation | 1.0 | |||
| Coefficient Of Variation | 739.68 | |||
| Standard Deviation | 5.28 | |||
| Variance | 27.9 | |||
| Information Ratio | 0.1155 | |||
| Jensen Alpha | 0.667 | |||
| Total Risk Alpha | 0.0315 | |||
| Sortino Ratio | 0.6075 | |||
| Treynor Ratio | 1.78 | |||
| Maximum Drawdown | 42.94 | |||
| Value At Risk | (0.49) | |||
| Potential Upside | 1.24 | |||
| Downside Variance | 1.01 | |||
| Semi Variance | (0.30) | |||
| Expected Short fall | (1.53) | |||
| Skewness | 7.79 | |||
| Kurtosis | 62.45 |
Avidity Biosciences Backtested Returns
At this point, Avidity Biosciences is very steady. Avidity Biosciences secures Sharpe Ratio (or Efficiency) of 0.23, which signifies that the company had a 0.23 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Avidity Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Avidity Biosciences' Coefficient Of Variation of 739.68, mean deviation of 1.44, and Risk Adjusted Performance of 0.1084 to double-check if the risk estimate we provide is consistent with the expected return of 0.0602%. Avidity Biosciences has a performance score of 17 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.4, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Avidity Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Avidity Biosciences is expected to be smaller as well. Avidity Biosciences right now shows a risk of 0.27%. Please confirm Avidity Biosciences downside variance, and the relationship between the treynor ratio and kurtosis , to decide if Avidity Biosciences will be following its price patterns.
Auto-correlation | 0.74 |
Good predictability
Avidity Biosciences has good predictability. Overlapping area represents the amount of predictability between Avidity Biosciences time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Avidity Biosciences price movement. The serial correlation of 0.74 indicates that around 74.0% of current Avidity Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.74 | |
| Spearman Rank Test | 0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 0.11 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Avidity Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Avidity Biosciences reported net income of (322.3 Million). This is 194.44% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 156.45% higher than that of the company.
Avidity Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avidity Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avidity Biosciences could also be used in its relative valuation, which is a method of valuing Avidity Biosciences by comparing valuation metrics of similar companies.Avidity Biosciences is currently under evaluation in net income category among its peers.
Avidity Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Avidity Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Avidity Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Avidity Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Avidity Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Avidity Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Avidity Biosciences' value.| Shares | Geode Capital Management, Llc | 2025-06-30 | 2.8 M | Bank Of America Corp | 2025-06-30 | 1.8 M | Orbimed Advisors, Llc | 2025-06-30 | 1.8 M | Casdin Capital, Llc | 2025-06-30 | 1.8 M | Polar Capital Holdings Plc | 2025-06-30 | 1.8 M | Adage Capital Partners Gp Llc | 2025-06-30 | 1.5 M | Goldman Sachs Group Inc | 2025-06-30 | 1.1 M | Siren, L.l.c. | 2025-06-30 | 1.1 M | Charles Schwab Investment Management Inc | 2025-06-30 | 1 M | Fmr Inc | 2025-06-30 | 16.2 M | T. Rowe Price Associates, Inc. | 2025-06-30 | 10.8 M |
Avidity Fundamentals
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.2 | ||||
| Operating Margin | (15.13) % | ||||
| Current Valuation | 9.09 B | ||||
| Shares Outstanding | 150.68 M | ||||
| Shares Owned By Insiders | 4.12 % | ||||
| Shares Owned By Institutions | 95.88 % | ||||
| Number Of Shares Shorted | 8.79 M | ||||
| Price To Earning | (12.91) X | ||||
| Price To Book | 5.79 X | ||||
| Price To Sales | 524.56 X | ||||
| Revenue | 10.9 M | ||||
| Gross Profit | (467.32 M) | ||||
| EBITDA | (376.16 M) | ||||
| Net Income | (322.3 M) | ||||
| Cash And Equivalents | 398.22 M | ||||
| Cash Per Share | 7.64 X | ||||
| Total Debt | 6.8 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 12.00 X | ||||
| Book Value Per Share | 12.85 X | ||||
| Cash Flow From Operations | (300.87 M) | ||||
| Short Ratio | 4.09 X | ||||
| Earnings Per Share | (4.19) X | ||||
| Target Price | 74.64 | ||||
| Number Of Employees | 391 | ||||
| Beta | 0.96 | ||||
| Market Capitalization | 10.95 B | ||||
| Total Asset | 1.56 B | ||||
| Retained Earnings | (893.07 M) | ||||
| Working Capital | 1.44 B | ||||
| Current Asset | 50.65 M | ||||
| Current Liabilities | 16.97 M | ||||
| Net Asset | 1.56 B |
About Avidity Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avidity Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avidity Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avidity Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Avidity Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avidity Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avidity Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avidity Biosciences Stock:Check out Avidity Biosciences Piotroski F Score and Avidity Biosciences Altman Z Score analysis. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. If investors know Avidity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avidity Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.19) | Revenue Per Share | Quarterly Revenue Growth 4.34 | Return On Assets | Return On Equity |
The market value of Avidity Biosciences is measured differently than its book value, which is the value of Avidity that is recorded on the company's balance sheet. Investors also form their own opinion of Avidity Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Avidity Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avidity Biosciences' market value can be influenced by many factors that don't directly affect Avidity Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avidity Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avidity Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avidity Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.